Pages that link to "Q35162123"
Jump to navigation
Jump to search
The following pages link to Comparison of bevacizumab and ranibizumab in age-related macular degeneration: a systematic review and meta-analysis (Q35162123):
Displaying 7 items.
- Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration (Q24193614) (← links)
- Intravitreal anti-VEGF injections for treating wet age-related macular degeneration: a systematic review and meta-analysis (Q26785646) (← links)
- SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB. (Q30490738) (← links)
- Overview of the Safety of Anti-VEGF Drugs: Analysis of the Italian Spontaneous Reporting System (Q38741548) (← links)
- When important steps for a reliable meta-analysis are missing: the bevacizumab versus ranibizumab case (Q43143643) (← links)
- Comparative safety profiles of intravitreal bevacizumab, ranibizumab and pegaptanib: the analysis of the WHO database of adverse drug reactions (Q56972032) (← links)
- The safety of bevacizumab and ranibizumab in clinical studies (Q86648810) (← links)